| Literature DB >> 28778161 |
Catherine Hudon1,2, Josiane Courteau3, Cynthia Krieg3, Alain Vanasse3,4.
Abstract
BACKGROUND: A small proportion of patients utilizes a disproportionately large amount of emergency department (ED) resources. Being able to properly identify chronic frequent ED users, i.e. frequent ED users over a multiple-year period, would allow healthcare professionals to intervene before it occurs and, if possible, redirect these patients to more appropriate health services. The objective of this study was to explore the factors associated with chronic frequent ED utilization in a population with diabetes.Entities:
Keywords: Administrative data; Diabetes; Emergency department; Frequent use
Mesh:
Year: 2017 PMID: 28778161 PMCID: PMC5544976 DOI: 10.1186/s12913-017-2453-3
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Comorbidities and their associated classification codes*
| Comorbidity | ICD-9 | ICD-10 |
|---|---|---|
| Mental health comorbidities | ||
| Any mental health dis. | 290–319 | F00-F99 |
| Substance abuse | 291, 292, 303, 304, 305 | F10-F19, F55 |
| Dementia | 290, 291, 294 | F00-F06, F09, F10 |
| Other mental health dis. | 290–319 except 290–292, 294, 303, 304, 305 | F00-F99 except F00-F06, F09 -F19, F55 |
| Physical comorbidities | ||
| Complication of diabetes | 250.1–250.9 | E10-E14 not E10.9 |
| High blood pressure | 401–405 | I10-I15 |
| Dyslipidemia | 272 | E78, E75.2–3–5-6, E77.0–9, E88.1–2, H026 |
| Injury | 800–999 | S00-T99 |
| Cardiovascular disease (CVD): | ||
| Myocardial infarction | 410, 411 | I20.0, I21, I22, I24, I51.3 |
| Congestive heart failure | 298, 402, 428 | I09.0, I11, I50 |
| Peripheral vascular disease | 440–447 | I70-I77 |
| Cerebrovascular disease | 430–435 | G45.0-G45.2, G45.4, G45.8, G45.9, I60-I62 |
| Chronic obstructive pulmonary disease (COPD) | 491–493 | J41-J45 |
| Connective tissue disease | 710, 714, 725 | M05, M06, M08, M09, M12, M32-M36, L871 |
| Ulcer disease | 531–534 | K25-K28 |
| Liver disease | 571, 573 | K70, K71, K73-K77 |
| 070, 570, 572 | B15-B19, K72 | |
| Renal disease | 403–404, 580–586 | I12-I13, N00, N01, N03-N05, N07, N08, N14, N17-N19, N150, N16.3, N29.0 |
| Cancer: | ||
| Any tumor | 140–195 | C00-C76 |
| Leukemia | 204–208 | C91-C95 |
| Lymphoma | 200–203 | C81-C86, C88, C90, C96 |
| Metastatic solid tumor | 196–199 | C77-C80, C97 |
*The majority of the comorbidities are conditions listed in the D’Hoore adaptation of the Charlson comorbidity index
Fig. 1Study cohort flow diagram. * A patient was considered living with diabetes if he/she received a diagnosis of diabetes (ICD-9: 250; ICD-10: E10-E14) during a hospitalization or at least three physician claims within 1 year with an identical diagnosis. ** MA: Metropolitan area
Characteristics of the study cohort living with diabetes and factors associated with the risk of being a chronic frequent ED user (CFU)
| Characteristics | Total, n (%) | Non-CFUs, n (%) | CFUs, n (%) | Crude OR (95% CI) | Age-sex adj. OR* (95% CI) | Fully adj. OR |
|---|---|---|---|---|---|---|
| Total, n (%) | 62,316 (100) | 60,710 (97.4) | 1606 (2.6) | − | − | − |
| Sex | ||||||
| Male | 30,938 (49.6) | 30,457 (50.2) | 685 (42.6) | Ref | Ref | Ref |
| Female | 31,378 (50.4) | 30,253 (49.8) | 921 (57.4) | 1.34 (1.21–1.48) | 1.34 (1.21–1.48) | 1.27 (1.14–1.41) |
| Age group | ||||||
| 30–54 years | 14,801 (22.6) | 13,618 (22.4) | 463 (28.8) | Ref | Ref | Ref |
| 55–64 years | 14,949 (24.0) | 14,646 (24.1) | 303 (18.9) | 0.61 (0.52–0.70) | 0.62 (0.53–0.71) | 0.62 (0.53–0.72) |
| 65–74 years | 16,214 (26.0) | 15,803 (26.0) | 411 (25.6) | 0.76 (0.67–0.88) | 0.76 (0.67–0.87) | 0.76 (0.66–0.88) |
| 75 + years | 17,072 (27.4) | 16,643 (27.4) | 429 (26.7) | 0.76 (0.66–0.87) | 0.73 (0.64–0.84) | 0.73 (0.62–0.85) |
| Material deprivation | 22,239 (35.7) | 21,551 (35.5) | 688 (42.8) | 1.36 (1.23–1.51) | 1.34 (1.21–1.48) | 1.28 (1.16–1.42) |
| Social deprivation | 32,054 (51.4) | 31,089 (51.2) | 965 (60.1) | 1.43 (1.30–1.59) | 1.42 (1.28–1.57) | 1.28 (1.15–1.42) |
| Affiliation to a GP | 37,227 (59.7) | 36,383 (59.9) | 844 (52.6) | 0.74 (0.67–0.82) | 0.77 (0.69–0.85) | 0.81 (0.73–0.89) |
| Visit to an endocrinologist | 11,941 (19.2) | 11,605 (19.1) | 336 (20.9) | 1.12 (0.99–1.26) | 1.09 (0.96–1.23) | 1.10 (0.97–1.25) |
| Visit to an ophthalmologist | 22,974 (36.9) | 22,404 (36.9) | 570 (35.5) | 0.94 (0.85–1.04) | 0.96 (0.87–1.07) | 1.00 (0.90–1.12) |
| Visit to an internist | 10,480 (16.8) | 10,154 (16.7) | 326 (20.3) | 1.27 (1.12–1.44) | 1.29 (1.14–1.45) | 1.07 (0.94–1.21) |
| Substance abuse | 2665 (4.3) | 2457 (4.1) | 208 (13.0) | 3.53 (3.03–4.10) | 3.60 (3.09–4.19) | 2.04 (1.71–2.43) |
| Dementia | 4011 (6.4) | 3849 (6.3) | 162 (10.1) | 1.66 (1.40–1.96) | 1.74 (1.47–2.07) | 0.61 (0.50–0.75) |
| Other mental disorder | 13,967 (22.4) | 13,305 (21.9) | 662 (41.2) | 2.50 (2.26–2.76) | 2.41 (2.17–2.67) | 1.91 (1.72–2.13) |
| Hospitalization in 2006 | 28,664 (46.0) | 27,655 (45.6) | 1009 (62.8) | 2.02 (1.82–2.24) | 2.10 (1.89–2.33) | 1.03 (0.89–1.19) |
| Charlson Comorbidity index (CCI) | ||||||
| 0 | 32,716 (52.5) | 32,226 (53.1) | 490 (30.5) | Ref | Ref | Ref |
| 1 | 10,959 (17.6) | 10,601 (17.5) | 358 (22.3) | 2.22 (1.94–2.55) | 2.39 (2.08–2.74) | 1.56 (1.31–1.86) |
| 2 | 7937 (12.7) | 7694 (12.7) | 243 (15.1) | 2.08 (1.78–2.43) | 2.38 (2.04–2.80) | 1.77 (1.42–2.21) |
| 3 + | 10,704 (17.2) | 10,189 (16.8) | 515 (32.1) | 3.32 (2.93–3.77) | 3.96 (3.47–4.52) | 2.21 (1.63–2.99) |
| Complications of diabetes | 22,778 (36.6) | 21,982 (36.2) | 796 (49.6) | 1.73 (1.57–1.91) | 1.78 (1.61–1.97) | 1.08 (0.96–1.23) |
| High blood pressure | 27,639 (44.4) | 26,791 (44.1) | 848 (52.8) | 1.42 (1.28–1.56) | 1.51 (1.36–1.68) | 0.99 (0.88–1.11) |
| Dyslipidemia | 12,640 (20.3) | 12,186 (20.1) | 454 (28.3) | 1.57 (1.40–1.75) | 1.65 (1.48–1.84) | 0.95 (0.84–1.08) |
| Injury | 24,845 (39.9) | 23,943 (39.4) | 902 (56.2) | 1.97 (1.78–2.17) | 1.96 (1.78–2.17) | 1.71 (1.54–1.89) |
| COPD | 7657 (12.3) | 7161 (11.8) | 496 (30.9) | 3.34 (3.00–3.72) | 3.34 (3.00–3.73) | 2.01 (1.75–2.30) |
| CVD | 14,513 (23.3) | 13,955 (23.0) | 558 (34.7) | 1.78 (1.61–1.98) | 2.00 (1.80–2.23) | 1.11 (0.95–1.28) |
| Cancer | 7467 (12.0) | 7247 (11.9) | 220 (13.7) | 1.17 (1.01–1.35) | 1.24 (1.08–1.44) | 0.78 (0.64–0.96) |
| Renal disease | 7575 (12.2) | 7231 (11.9) | 344 (21.4) | 2.02 (1.78–2.28) | 2.18 (1.93–2.47) | 1.08 (0.90–1.30) |
| Liver disease | 2422 (3.9) | 2282 (3.8) | 140 (8.7) | 2.44 (2.05–2.92) | 2.47 (2.06–2.95) | 1.27 (1.04–1.56) |
| Connective tissue dis | 1298 (2.1) | 1253 (2.1) | 45 (2.8) | 1.37 (1.01–1.85) | 1.34 (0.99–1.82) | 0.94 (0.69–1.29) |
| Ulcer disease | 1041 (1.7) | 989 (1.6) | 52 (3.2) | 2.02 (1.52–2.68) | 2.11 (1.59–2.80) | 1.27 (0.94–1.70) |
*Adjusted only for age and sex. For the variables age and sex, the model is adjusted for the other variable
†Adjusted for all variables of Table 2
Fig. 2Risk of being a chronic frequent ED user (CFU) in a population with diabetes: multiple logistic regression analysis* (n = 62,316). *Adjusted for all independent variables (fully adjusted model)
Fig. 3Risk profiles of being a chronic frequent ED user (CFU) in a women population with diabetes: tree-based approach*. *In each box, n represents the number of CFUs and N the total number of patients (CFUs and Non-CFUs). The percent represents the proportion of CFUs in the subgroup
Fig. 4Risk profiles of being a chronic frequent ED user (CFU) in a men population with diabetes: tree-based approach*. *In each box, n represents the number of CFUs and N the total number of patients (CFUs and Non-CFUs). The percent represents the proportion of CFUs in the subgroup